Skip to main content

Table 3 Conformality and V20 constraints, as per the RTOG 0813 protocol [16]

From: Assessment of precision irradiation in early non-small cell lung cancer and interstitial lung disease (ASPIRE-ILD): study protocol for a phase II trial

PTV Volume (cc)

Ratio of prescription isodose volume to the PTV bolume (R100)

Ratio of 50% prescription isodose volume to the PTV volume, (R50)

Maximum dose (in % of dose prescribed) @ 2 cm from PTV in any direction, (D2cm) (Gy)

Percent of Lung receiving 20 Gy total or more (V20)

Deviation

Deviation

Deviation

Deviation

None

Minor

None

Minor

None

Minor

None

Minor

1.8

< 1.2

< 1.5

< 5.9

< 7.5

< 50.0

< 57.0

< 10

< 15

3.8

< 1.2

< 1.5

< 5.5

< 6.5

< 50.0

< 57.0

< 10

< 15

7.4

< 1.2

< 1.5

< 5.1

< 6.0

< 50.0

< 58.0

< 10

< 15

13.2

< 1.2

< 1.5

< 4.7

< 5.8

< 50.0

< 58.0

< 10

< 15

22.0

< 1.2

< 1.5

< 4.5

< 5.5

< 54.0

< 63.0

< 10

< 15

34.0

< 1.2

< 1.5

< 4.3

< 5.3

< 58.0

< 68.0

< 10

< 15

50.0

< 1.2

< 1.5

< 4.0

< 5.0

< 62.0

< 77.0

< 10

< 15

70.0

< 1.2

< 1.5

< 3.5

< 4.8

< 66.0

< 86.0

< 10

< 15

95.0

< 1.2

< 1.5

< 3.3

< 4.4

< 70.0

< 89.0

< 10

< 15

126.0

< 1.2

< 1.5

< 3.1

< 4.0

< 73.0

> 91.0

< 10

< 15

163.0

< 1.2

< 1.5

< 2.9

< 3.7

< 77.0

> 94.0

< 10

< 15